Objective to defend perindropil from price competition (Il Sole 24 Ore Radiocor)
– Brussels, 09 Jul – The EU Commission has imposed fines totaling 427.7 million euros on the French pharmaceutical company Servier and five manufacturers of generic drugs: Niche/Unichem, Matrix (which is part of the Mylan group), Teva, Krka and Lupin. Reason: They concluded a series of illegal deals to protect Servier's best-selling blood pressure drug perindopril from price competition from other generics in the EU.
Fine of 331 million to a French pharmaceutical company for blocking the entry of generics into the EU
Bruselas sanctions with 97 millones a otros 5 fabricantes de genéricos
Servier agreed with them to avoid competencies on your drug for hypertension
09.07.2014 AGENCIES rtve.es
The European Commission has imposed a fine of 331 million euros on the French farmacéutica servicing pactar acuerdos to prevent the entry into the market of a more cheap version of a cardiovascular drug. Cinco manufacturers of generic medicines that are accessed